Kim Nalee, Lim Do Hoon
Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Brain Tumor Res Treat. 2022 Apr;10(2):94-100. doi: 10.14791/btrt.2022.0003.
Optic pathway glioma (OPG) is a rare tumor located in optic nerve, optic tract, or optic chiasm. Treatment options for OPG include surgery, radiation therapy (RT), and chemotherapy. Although RT may provide favorable long-term outcomes in manner of either adjuvant or salvage aim, chemotherapy-first approach is increasingly performed due to possible late effects of RT. Proton beam RT may allow normal tissue sparing of radiation exposure compared to conventional X-ray treatment. Therefore, proton beam RT is expected to reduce complications from RT. This review discusses the recent updates on oncologic outcomes of OPG, late toxicities following RT, and compares the outcomes between X-ray treatment and proton beam RT.
视神经通路胶质瘤(OPG)是一种位于视神经、视束或视交叉的罕见肿瘤。OPG的治疗选择包括手术、放射治疗(RT)和化疗。尽管RT以辅助或挽救为目的可能会带来良好的长期疗效,但由于RT可能产生的后期影响,越来越多地采用先化疗的方法。与传统的X射线治疗相比,质子束RT可以使正常组织免受辐射。因此,预计质子束RT可减少RT的并发症。本综述讨论了OPG肿瘤学结局的最新进展、RT后的晚期毒性,并比较了X射线治疗和质子束RT之间的疗效。